% | $
Quotes you view appear here for quick access.

Biostar Pharmaceuticals, Inc. Message Board

  • cheapasianstocks cheapasianstocks Jan 25, 2010 1:35 PM Flag

    Potential uplist candidates


    BSPM- Biostar pharmaceuticals
    Background: BSPM develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for Chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, BioStar manufactures two broad-based OTC products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents.
    revenue: FY09 $33.9mm
    Net income: FY09 $6.69mm
    Year over year growth was over 100%

    CJJD (China JoJo Drugstores):
    Background: Chinese Retail Pharmacy
    The chain is differentiated among China’s highly fragmented drug store sector with a combined product offering of prescription, over-the-counter drugs, Western drugs, and Chinese Traditional Medicines. China Jo-Jo uniquely offers in-store access to physicians licensed in either Western or Eastern medicine. Two of the stores include clinics equipped for outpatient health care services.
    Quick Facts:
    Revenue: FY09: $44.7mm
    Net Income: $6.8mm
    EPS: $.34

    ONBI: Is a highly profitable company utilizing green processes to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on capitalizing on the rapidly growing markets of the Asia Pacific region.
    Quick Facts:
    Revenue: $41.3mm (forecasted)
    Net Income: $8.7mm (forecasted)

    LTUS:Lotus Pharmaceuticals develops and manufactures branded drugs and distributes its own drugs and pharmaceutical products produced by other manufacturers throughout the People’s Republic of China. The Company also owns and operates pharmacies in Beijing
    Quick Facts:
    Revenue: $68mm
    Net income $12.7mm
    EPS: $.27

    Other information can be found on
    Disclaimer: I have a position in CJJD and ONBI

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.90-0.04(-1.02%)3:01 PMEDT